Substanzen
Referenzverzeichnis analytischer Verbindungen: geprüfte IUPAC-Nomenklatur, CAS- und PubChem-Kennungen, Strukturprofil sowie dokumentierte Toxikologie- und Wechselwirkungsdaten.
Arylcyclohexylamine
11-
2-FDCK C13H16FNO
2-(2-fluorophenyl)-2-(methylamino)cyclohexan-1-one
-
3-HO-PCP C17H25NO
3-(1-piperidin-1-ylcyclohexyl)phenol
-
3-MeO-PCE C15H23NO
N-ethyl-1-(3-methoxyphenyl)cyclohexan-1-amine
-
3-MeO-PCP C18H27NO
1-[1-(3-methoxyphenyl)cyclohexyl]piperidine
-
DCK C13H17NO
2-(methylamino)-2-phenylcyclohexan-1-one
-
DMXE (Deoxymethoxetamine) C15H21NO
2-(ethylamino)-2-(3-methylphenyl)cyclohexan-1-one
-
FXE (Fluorexetamine) C14H18FNO
2-(ethylamino)-2-(3-fluorophenyl)cyclohexan-1-one
-
Ketamine C13H16ClNO
2-(2-chlorophenyl)-2-(methylamino)cyclohexan-1-one
-
MXE C15H21NO2
2-(ethylamino)-2-(3-methoxyphenyl)cyclohexan-1-one
-
O-DSMT (O-Desmethyltramadol) C15H23NO2
3-[(1R,2R)-2-[(dimethylamino)methyl]-1-hydroxycyclohexyl]phenol
-
O-PCE C14H19NO
2-(ethylamino)-2-phenylcyclohexan-1-one
Benzodiazepine und Thienodiazepine
9-
Bromazolam C17H13BrN4
8-bromo-1-methyl-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine
-
Clonazolam C17H12ClN5O2
6-(2-chlorophenyl)-1-methyl-8-nitro-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine
-
Desalkylgidazepam C17H13ClN4
8-chloro-1-methyl-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine
-
Diclazepam C16H12Cl2N2O
7-chloro-5-(2-chlorophenyl)-1-methyl-3H-1,4-benzodiazepin-2-one
-
Etizolam C17H15ClN4S
7-(2-chlorophenyl)-4-ethyl-13-methyl-3-thia-1,8,11,12-tetrazatricyclo[8.3.0.02,6]trideca-2(6),4,7,10,12-pentaene
-
Flualprazolam C17H12ClFN4
8-chloro-6-(2-fluorophenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine
-
Flubromazepam C15H10BrFN2O
7-bromo-5-(2-fluorophenyl)-1,3-dihydro-1,4-benzodiazepin-2-one
-
Norflurazepam C15H10ClFN2O
7-chloro-5-(2-fluorophenyl)-1,3-dihydro-1,4-benzodiazepin-2-one
-
Pyrazolam C16H12BrN5
8-bromo-1-methyl-6-pyridin-2-yl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine
Cathinon-Derivate
13-
2-CMC C10H12ClNO
1-(2-chlorophenyl)-2-(methylamino)propan-1-one
-
2-MMC C11H15NO
2-(methylamino)-1-(2-methylphenyl)propan-1-one
-
3-CMC C10H12ClNO
1-(3-chlorophenyl)-2-(methylamino)propan-1-one
-
3-MMC C11H15NO
2-(methylamino)-1-(3-methylphenyl)propan-1-one
-
4-CMC C10H12ClNO
1-(4-chlorophenyl)-2-(methylamino)propan-1-one
-
4-MMC C11H15NO
2-(methylamino)-1-(4-methylphenyl)propan-1-one
-
Eutylone (bk-EBDB) C13H17NO3
1-(1,3-benzodioxol-5-yl)-2-(ethylamino)butan-1-one
-
MDPHP C17H23NO3
1-(1,3-benzodioxol-5-yl)-2-pyrrolidin-1-ylhexan-1-one
-
N-Ethylhexedrone (Hexen) C14H21NO
2-(ethylamino)-1-phenylhexan-1-one
-
NEP C13H19NO
2-(ethylamino)-1-phenylpentan-1-one
-
α-PHiP C16H23NO
4-methyl-1-phenyl-2-pyrrolidin-1-ylpentan-1-one
-
α-PHP C16H23NO
1-phenyl-2-pyrrolidin-1-ylhexan-1-one
-
α-PVP C15H21NO
1-phenyl-2-pyrrolidin-1-ylpentan-1-one
Cannabinoide (Indazolcarboxamide)
6-
4F-MDMB-BINACA C19H26FN3O3
methyl (2S)-2-[[1-(4-fluorobutyl)indazole-3-carbonyl]amino]-3,3-dimethylbutanoate
-
5F-MDMB-PINACA C20H28FN3O3
methyl (2S)-2-[[1-(5-fluoropentyl)indazole-3-carbonyl]amino]-3,3-dimethylbutanoate
-
ADB-BUTINACA C18H26N4O2
N-[(2S)-1-amino-3,3-dimethyl-1-oxobutan-2-yl]-1-butylindazole-3-carboxamide
-
ADB-FUBINACA C21H23FN4O2
N-[(2S)-1-amino-3,3-dimethyl-1-oxobutan-2-yl]-1-[(4-fluorophenyl)methyl]indazole-3-carboxamide
-
ADB-PINACA C19H28N4O2
N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentylindazole-3-carboxamide
-
MDMB-4en-PINACA C20H27N3O3
methyl (2S)-3,3-dimethyl-2-[(1-pent-4-enylindazole-3-carbonyl)amino]butanoate
Lysergamide
6-
1cP-LSD C24H29N3O2
(6aR,9R)-4-(cyclopropanecarbonyl)-N,N-diethyl-7-methyl-6,6a,8,9-tetrahydroindolo[4,3-fg]quinoline-9-carboxamide
-
1P-LSD C23H29N3O2
(6aR,9R)-N,N-diethyl-7-methyl-4-propanoyl-6,6a,8,9-tetrahydroindolo[4,3-fg]quinoline-9-carboxamide
-
1V-LSD C25H33N3O2
(6aR,9R)-N,N-diethyl-7-methyl-4-pentanoyl-6,6a,8,9-tetrahydroindolo[4,3-fg]quinoline-9-carboxamide
-
AL-LAD C22H27N3O
(6aR,9R)-N,N-diethyl-7-prop-2-enyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide
-
ETH-LAD C21H27N3O
(6aR,9R)-N,N,7-triethyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide
-
LSD-25 C20H25N3O
(6aR,9R)-N,N-diethyl-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide
Organische Vorstoffe
3Phenethylamin-Derivate
16-
2-FMA C10H14FN
1-(2-fluorophenyl)-N-methylpropan-2-amine
-
25I-NBOMe C18H22INO3
2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine
-
2C-B C10H14BrNO2
2-(4-bromo-2,5-dimethoxyphenyl)ethanamine
-
2C-C C10H14ClNO2
2-(4-chloro-2,5-dimethoxyphenyl)ethanamine
-
2C-D C11H17NO2
2-(2,5-dimethoxy-4-methylphenyl)ethanamine
-
2C-E C12H19NO2
2-(4-ethyl-2,5-dimethoxyphenyl)ethanamine
-
2C-H C10H15NO2
2-(2,5-dimethoxyphenyl)ethanamine
-
2C-I C10H14INO2
2-(4-iodo-2,5-dimethoxyphenyl)ethanamine
-
3-FA C9H12FN
1-(3-fluorophenyl)propan-2-amine
-
4-FA C9H12FN
1-(4-fluorophenyl)propan-2-amine
-
4-FMA C10H14FN
1-(4-fluorophenyl)-N-methylpropan-2-amine
-
4F-MPH C14H18FNO2
methyl (2R)-2-(4-fluorophenyl)-2-[(2R)-piperidin-2-yl]acetate
-
5-MAPB C12H15NO
1-(1-benzofuran-5-yl)-N-methylpropan-2-amine
-
6-APB C11H13NO
1-(1-benzofuran-6-yl)propan-2-amine
-
6-MAPB C12H15NO
1-(1-benzofuran-6-yl)-N-methylpropan-2-amine
-
IPPH (Isopropylphenidate) C16H23NO2
propan-2-yl 2-phenyl-2-piperidin-2-ylacetate
Tryptamin-Derivate
6-
4-AcO-DMT C14H18N2O2
[3-[2-(dimethylamino)ethyl]-1H-indol-4-yl] acetate
-
4-HO-MET C13H18N2O
3-[2-[ethyl(methyl)amino]ethyl]-1H-indol-4-ol
-
4-HO-MiPT C14H20N2O
3-[2-[methyl(propan-2-yl)amino]ethyl]-1H-indol-4-ol
-
5-MeO-DMT C13H18N2O
2-(5-methoxy-1H-indol-3-yl)-N,N-dimethylethanamine
-
5-MeO-MiPT C15H22N2O
N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-N-methylpropan-2-amine
-
N,N-DMT C12H16N2
2-(1H-indol-3-yl)-N,N-dimethylethanamine